Evaluation of solvent/detergent-treated plasma in patients with a prolonged prothrombin time

被引:30
作者
Lerner, RG
Nelson, J
Sorcia, E
Grima, K
Kancherla, RR
Zarou-Naimo, CM
Pehta, JC
机构
[1] New York Med Coll, Dept Med, Hematol Sect, Valhalla, NY 10595 USA
[2] New York Med Coll, Transfus Serv, Valhalla, NY 10595 USA
[3] Westchester Cty Med Ctr, Valhalla, NY 10595 USA
[4] VI Technol Inc, Watertown, MA USA
关键词
D O I
10.1046/j.1423-0410.2000.7930161.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To compare the laboratory and clinical outcome of patients who received solvent/detergent-treated plasma (SDP) and fresh-frozen plasma (FFP), Methods: A randomized, double-blinded study to assess the ability of SDP and FFP to reduce a prolonged prothrombin time (PT) to less than or equal to 15 s in patients with acquired coagulation deficits, Results: 45 patients (22 SDP vs, 23 FFP) were treated with 71 infusions. There were no significant differences in mean dose of plasma infused (7.8 ml/kg for SDP vs. 8.0 ml/kg for FFP, p = 0.46], percentage of patients who corrected their PT to less than or equal to 15 s (32% for SDP vs, 26% for FFP, p = 0.67), or percentage of patients whose bleeding ceased (27% for SDP vs. 22% for FFP). Conclusion: No clinical or statistically significant differences were observed after infusion with SDP or FFP in patients with acquired coagulation deficits. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 18 条
[1]  
ABUELMAGD KM, 1993, SURGERY, V114, P868
[2]  
BERNSTEIN MJ, 1985, JAMA-J AM MED ASSOC, V253, P551
[3]   Solvent/detergent treatment of human plasma -: A very robust method for virus inactivation.: Validated virus safety of OCTAPLAS® [J].
Blesert, L ;
Suhartono, H .
VOX SANGUINIS, 1998, 74 :207-212
[4]  
DIPAOLANTONIO T, 1992, J MED VIROL, V36, P71, DOI 10.1002/jmv.1890360202
[5]   Solvent detergent fresh frozen plasma as primary treatment of acute thrombotic thrombocytopenic purpura [J].
Evans, G ;
Llewelyn, C ;
Luddington, R ;
Baglin, TP ;
Williamson, LM .
CLINICAL AND LABORATORY HAEMATOLOGY, 1999, 21 (02) :119-123
[6]   A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during orthotopic liver transplantation [J].
Freeman, JW ;
Williamson, LM ;
Llewelyn, C ;
Fisher, N ;
Allain, JP ;
Bellamy, M ;
Baglin, TP ;
Klinc, J ;
Ala, FA ;
Smith, N ;
Neuberger, J ;
Wreghitt, T .
VOX SANGUINIS, 1998, 74 :225-229
[7]   VIRAL SAFETY OF SOLVENT DETERGENT-TREATED BLOOD PRODUCTS [J].
HOROWITZ, B ;
PRINCE, AM ;
HAMMAN, J ;
WATKLEVICZ, C .
BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 :S21-S30
[8]  
HOROWITZ B, 1992, BLOOD, V79, P826
[9]  
HOROWITZ MS, 1988, LANCET, V2, P186
[10]  
HOROWITZ MS, 1990, 19 INT C WORLD FED H, P27